ReviewAdvances and technical standards in neurosurgery2026
Movement Disorders in Children: Treatment Algorithm and Surgical Options.
Review in Advances and technical standards in neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paediatric movement disorders (PMDs) encompass a wide range of diseases resulting from countless aetiologies. These are distinct from their adult counterparts, with a far greater proportion of genetic mutations, perinatal injuries, metabolic disorders, and in many cases, undefined neurodevelopmental abnormalities. Given the complexity of both the diagnostic process and management pathway of PMDs, early identification is critical to guide appropriate intervention in a timely manner. Through early recognition and management, clinicians positively impact neurodevelopment, quality of life, and long-term functional outcomes in children with PMDs.Effective management of PMDs necessitates the cooperation of an extensive multidisciplinary team of healthcare professionals, including neurologists, physiotherapists, occupational therapists, psychologists, and neurosurgeons. Each specialist brings their own perspective and expertise to best manage these complex patients.The initial treatment of paediatric movement disorders is widely centred on pharmacotherapy, with medications guided by underlying aetiology and symptoms. As such, medical management can be seen as treating either the manifestation and symptoms of the movement disorder, or in the case of autoimmune or inflammatory aetiologies, the underlying disease process. As a result, by the time patients have been referred for a neurosurgical opinion they have often trialled a number of different pharmacotherapies.Surgical intervention in paediatric movement disorders is considered when conservative treatment has failed to provide adequate symptom control or when the disorder significantly impairs the child's quality of life. The decision to proceed with surgery is multifaceted, involving careful patient selection, multidisciplinary evaluation, and consideration of the specific movement disorder phenotype.This chapter integrates contemporary literature to propose a reliable framework with which neurosurgeons can approach paediatric movement disorders, with a specific focus on neurosurgical options, including deep brain stimulation (DBS), pallidotomy, and rhizotomy.
Indexed as
Identifiers
42393454What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.